Acadia Healthcare (NASDAQ:ACHC) Rating Increased to Hold at Zacks Research

Zacks Research upgraded shares of Acadia Healthcare (NASDAQ:ACHC) from a strong sell rating to a hold rating in a research report report published on Thursday morning,Zacks.com reports.

ACHC has been the topic of several other reports. Barclays upped their price target on Acadia Healthcare from $14.00 to $20.00 and gave the stock an “equal weight” rating in a research note on Tuesday. UBS Group boosted their target price on shares of Acadia Healthcare from $24.00 to $27.00 and gave the company a “buy” rating in a report on Thursday, February 26th. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Acadia Healthcare from $33.00 to $20.00 and set a “buy” rating on the stock in a research report on Wednesday, December 3rd. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, January 21st. Finally, Guggenheim dropped their price objective on shares of Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating on the stock in a research note on Monday, February 23rd. Seven analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $21.15.

Acadia Healthcare Trading Up 3.9%

ACHC stock traded up $0.96 on Thursday, reaching $25.62. The company’s stock had a trading volume of 4,445,074 shares, compared to its average volume of 4,206,903. The business has a fifty day simple moving average of $15.80 and a two-hundred day simple moving average of $18.69. Acadia Healthcare has a 12-month low of $11.43 and a 12-month high of $31.43. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.44 and a current ratio of 1.55. The firm has a market cap of $2.36 billion, a PE ratio of -2.10, a PEG ratio of 8.33 and a beta of 0.74.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, February 25th. The company reported $0.07 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.04. The firm had revenue of $821.46 million for the quarter, compared to analyst estimates of $800.10 million. Acadia Healthcare had a negative net margin of 33.29% and a positive return on equity of 6.53%. The company’s revenue for the quarter was up 6.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.64 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. As a group, research analysts forecast that Acadia Healthcare will post 3.38 EPS for the current year.

Hedge Funds Weigh In On Acadia Healthcare

Institutional investors and hedge funds have recently modified their holdings of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in Acadia Healthcare during the 1st quarter valued at about $1,600,000. Goldman Sachs Group Inc. raised its holdings in Acadia Healthcare by 21.1% in the first quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock worth $21,170,000 after buying an additional 121,444 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Acadia Healthcare by 8.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock worth $10,337,000 after buying an additional 27,207 shares in the last quarter. Envestnet Asset Management Inc. grew its holdings in shares of Acadia Healthcare by 54.2% during the second quarter. Envestnet Asset Management Inc. now owns 166,880 shares of the company’s stock valued at $3,786,000 after buying an additional 58,642 shares during the last quarter. Finally, Campbell & CO Investment Adviser LLC increased its position in shares of Acadia Healthcare by 119.0% during the second quarter. Campbell & CO Investment Adviser LLC now owns 74,717 shares of the company’s stock valued at $1,695,000 after acquiring an additional 40,592 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.